| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/14/2002 | DE10043074A1 Herbizid wirksame Benzoylcyclohexandione Herbicide effective benzoylcyclohexanediones |
| 03/14/2002 | DE10040901A1 Neue Phenyl- und Phenylalkyl-substituierte Ethanolamine und Ethylendiamine New phenyl and phenylalkyl substituted ethanolamines and ethylenediamines |
| 03/13/2002 | EP1186946A1 Photographic material containing a novel hydrazine type |
| 03/13/2002 | EP1186318A2 Combination, for treating depression and anxiety, containing a 5HT1d receptor antagonist and aCNS penetrant NK-1 receptor antagonist |
| 03/13/2002 | EP1185527A1 1-(p-thienylbenzyl)-imidazoles as angiotensin-(1-7) receptor agonists, method for the production and the utilization thereof and pharmaceutical preparations containing said compounds |
| 03/13/2002 | EP1185522A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions containing them |
| 03/13/2002 | EP1185521A1 Substituted 1-aza-2-imino-heterocycles and their use as activators of nicotinic acetylcholine receptors |
| 03/13/2002 | EP1185509A2 INHIBITORS OF FACTOR Xa |
| 03/13/2002 | EP1185508A2 Inhibitors of factor xa |
| 03/13/2002 | CN1340043A Phenylalaninol derivatives |
| 03/13/2002 | CN1340040A Stabilised compositions of 0-and N-vinyl compounds and the use of ammonium salts as stabilisers |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355672 Bone disorders; central nervous system disorders |
| 03/12/2002 | US6355665 1H-4(5)-substituted imidazole derivatives, their preparation and their use as histamine H3 receptor ligands |
| 03/12/2002 | US6355664 Phenylpyrrolidines, phenylimidazolidines, 3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease |
| 03/12/2002 | US6355662 Peptide and nonpeptides autoimmune diseases, antiinflammatory agents |
| 03/12/2002 | US6355643 Enzyme inhibitors, ras genes and proteins |
| 03/12/2002 | US6355635 Imidazolebenzene, imidazolepyridine compounds for treatment of obesity |
| 03/12/2002 | US6355231 Use of cationic copolymers of unsaturated acids and N-vinylimidazolium salts in cosmetic hair formulations |
| 03/07/2002 | WO2002018368A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/07/2002 | WO2002018365A1 N-heteroarylmethyl-p-phenylendiamine derivatives and compounds containing oxidation colouring agents |
| 03/07/2002 | WO2002018361A2 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | WO2002018347A1 Method for the production of n,n'-carbonyldiazoles and azolide salts |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | WO2001062765A3 Small molecule modulators of g protein-coupled receptor six |
| 03/07/2002 | US20020028952 New family of ring compounds based on 2-vinyl-4,5-dicyanoimidazoles; for cost effective synthesis of polyimidazoles |
| 03/07/2002 | US20020028951 Process for preparing eprosartan |
| 03/07/2002 | US20020028949 Synthesis of (R)-3-(4-Bromobenzyl)-1-(3,5-dichlorophenyl)-5-iodo-3-methyl-1-H-imidazo[1,2-a]imidazol-2-one |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028933 Thioamide derivatives |
| 03/07/2002 | US20020028851 Guanylhydrazones and their use to treat inflammatory conditions |
| 03/07/2002 | US20020028842 Reducing the vomiting side effects of phosphodiesterase inhibitors, e.g. Rolipram, Ariflo, by benzylation by benzyl bromide or a derivative |
| 03/07/2002 | US20020028841 Thienopyrrolidinones |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/07/2002 | US20020028809 Heterocyclic compounds having effect of activating a4beta2 nicotinic acetylcholine receptors |
| 03/07/2002 | US20020028781 Antibiotics |
| 03/07/2002 | DE10041423A1 Biphenylderivate Biphenyl |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2420673A1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors |
| 03/06/2002 | EP1184382A1 Oxime derivatives, process for the preparation thereof and pesticides |
| 03/06/2002 | EP1183274A1 Method and compounds for inhibiting activity of serine elastases |
| 03/06/2002 | EP1183235A2 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183234A1 INHIBITORS OF FACTOR Xa |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/06/2002 | EP0819122B1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 03/06/2002 | CA2356797A1 Combination treatment for depression and anxiety |
| 03/05/2002 | US6353136 Process for preparing aromatic amines in the presence of palladaphosphacyclobutane catalysts |
| 03/05/2002 | US6353115 Method for producing carbonyl diimidazoles |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6353013 Antiinflammatory agents |
| 02/28/2002 | WO2002016319A1 Novel thiourea compounds and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002016318A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/28/2002 | WO2002015905A1 The use of histamine h3 receptor inverse agonists for the control of appetite and treatment of obesity |
| 02/28/2002 | WO2001074741A3 Catalytic asymmetric desymmetrization of meso compounds |
| 02/28/2002 | WO2001070720A3 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 02/28/2002 | WO2001068654A3 Tubulin binding ligands and corresponding prodrug constructs |
| 02/28/2002 | WO2001068600A3 Benzylated pde4 inhibitors |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020025980 Single morphic forms of metalloproteinase inhibitors |
| 02/28/2002 | US20020025965 Antiserotonine agents |
| 02/28/2002 | US20020025963 Novel guanidine mimics as factor Xa inhibitors |
| 02/28/2002 | US20020025947 Serine protease inhibitor |
| 02/28/2002 | US20020025574 Device for detection of preferential particles in solution; for use in detection of allergies |
| 02/28/2002 | CA2417507A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 02/27/2002 | EP1182203A1 Azole compounds and herbicide compositions |
| 02/27/2002 | EP1182197A1 Single step preparation of ionic fluids |
| 02/27/2002 | EP1182196A1 Halogenide-free preparation of ionic fluids |
| 02/27/2002 | EP1181280A1 Substituted benzoyl ketones, methods for producing them and their use as herbicides |
| 02/27/2002 | EP1181279A1 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 02/27/2002 | EP1181271A2 Naphthalene ureas as glucose uptake enhancers |
| 02/27/2002 | EP1181014A1 HETEROCYCLIC CONTAINING BIPHENYL aP2 INHIBITORS AND METHOD |
| 02/27/2002 | CN1337955A Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents |
| 02/27/2002 | CN1337953A New thryoid receptor ligands and process II |
| 02/27/2002 | CN1337941A Amide derivatives |
| 02/27/2002 | CN1337938A Novel method for preparing chiral amino acids |
| 02/27/2002 | CN1337395A Novel acardite compound, its preparation method and medicinal composition containing said compound |
| 02/27/2002 | CN1337394A Comprehensive cystine mother liquor utilizing process of producing single amino acid and eliminating pollution |
| 02/27/2002 | CN1079794C Ether compound, use thereof, and intermediate for producing the compound |
| 02/26/2002 | US6350902 Process for the selective N-formylation of N-hydroxylamines |
| 02/26/2002 | US6350885 Tricyclic heteroaromatics and their derivatives as inhibitors of matrix metalloproteinases |
| 02/26/2002 | US6350770 Microbiocides, insecticides |
| 02/26/2002 | CA2081605C Complex salts of hematoporphyrin and of its derivatives, their synthesis and therapeutic agent |
| 02/26/2002 | CA2063550C Azomethines agonist compounds of the histamine h3 receptor for therapeutic use, pharmaceutical compositions acting as agonists of said receptor and method of preparation |
| 02/21/2002 | WO2002014291A1 PPARδ ACTIVATORS |
| 02/21/2002 | WO2002014285A1 Substituted imidazoles as tafia inhibitors |
| 02/21/2002 | WO2002014267A1 Novel aminocyclohexane derivatives |
| 02/21/2002 | WO2002013821A1 Novel alicyclic imidazoles as h3 agents |
| 02/21/2002 | WO2001083423A3 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 02/21/2002 | WO2001058869B1 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 02/21/2002 | WO2001015175A3 Process for recycling ionic liquids |
| 02/21/2002 | WO2000054729A8 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 02/21/2002 | US20020022728 Nitrophenyl-sulfonyl-imidazoles and use thereof for controlling vegetable and animal pests |
| 02/21/2002 | US20020022628 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 02/21/2002 | US20020022622 Administering effective amount of oxalzole, thiazole or imidazole derivatives to cure diseases associated with protein aging |
| 02/21/2002 | DE10038747A1 Simplified purification of alkenyl compounds to low APHA color indexes, involves at least two distillations with time gap of at least one day after the first distillation |